Your browser doesn't support javascript.
loading
A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myeloma.
Iida, Shinsuke; Izumi, Tohru; Komeno, Takuya; Terui, Yasuhito; Chou, Takaaki; Ikeda, Takashi; Berg, Deborah; Fukunaga, Shinichi; Sugiura, Kenkichi; Sasaki, Makoto.
Affiliation
  • Iida S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Kawasumi 1, Mizuho-cho, Mizuoho-ku, Nagoya-shi, Aichi, Japan. iida@med.nagoya-cu.ac.jp.
  • Izumi T; Department of Hematology, Tochigi Cancer Center, Utsunomiya, Tochigi, Japan.
  • Komeno T; Department of Hematology, Sendai Medical Center, Sendai, Miyagi, Japan.
  • Terui Y; Department of Hematology, National Hospital Organization Mito Medical Center, Ibaraki, Japan.
  • Chou T; Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto, Tokyo, Japan.
  • Ikeda T; Department of Hematology, Saitama Medical University Hospital, Moroyama-machi, Saitama, Japan.
  • Berg D; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.
  • Fukunaga S; Niigata Kenshin Plaza, General Incorporated Foundation, Health Medicine Prevention Association, Niigata, Japan.
  • Sugiura K; Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Nagaizumi, Shizuoka, Japan.
  • Sasaki M; Clinical Research and Development, Takeda Pharmaceutical Company Limited, Osaka, Japan.
Int J Clin Oncol ; 27(1): 224-233, 2022 Jan.
Article in En | MEDLINE | ID: mdl-34599726

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Clinical_trials Limits: Adult / Humans Country/Region as subject: Asia Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Clinical_trials Limits: Adult / Humans Country/Region as subject: Asia Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Japan